Chronisch Lymphatische Leukämie Guidline and Quality indicator
0.2.0 - ci-build

Chronisch Lymphatische Leukämie Guidline and Quality indicator - Local Development build (v0.2.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: CLL Therapieindikation Binet C - JSON Representation

Active as of 2023-05

Raw json | Download

{
  "resourceType" : "PlanDefinition",
  "id" : "CLLTherapieindikationBinetC",
  "meta" : {
    "profile" : [
      🔗 "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/recommendation-plan"
    ]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: PlanDefinition CLLTherapieindikationBinetC</b></p><a name=\"CLLTherapieindikationBinetC\"> </a><a name=\"hcCLLTherapieindikationBinetC\"> </a><a name=\"CLLTherapieindikationBinetC-en-US\"> </a><p><b>partOf</b>: <a href=\"PlanDefinition-RecCollectionTherapieplanungBinetCLL.html\">Recommendation Collection CLL: Therapieindikation nach Binet Stadium (4.1)</a></p><blockquote><p><b>Action Combination Method</b></p><ul><li>method: <span title=\"Codes:{https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-action-combination-method all}\">All</span></li></ul></blockquote><p><b>knowledgeCapability</b>: computable</p><p><b>knowledgeRepresentationLevel</b>: structured</p><p><b>url</b>: <a href=\"PlanDefinition-CLLTherapieindikationBinetC.html\">PlanDefinition CLL Therapieindikation Binet C</a></p><p><b>version</b>: Langversion 2.01</p><p><b>name</b>: CLLTherapieindikationBinetC</p><p><b>title</b>: CLL Therapieindikation Binet C</p><p><b>type</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/plan-definition-type eca-rule}\">ECA Rule</span></p><p><b>status</b>: Active</p><p><b>experimental</b>: false</p><p><b>subject</b>: <a href=\"EvidenceVariable-PopulationCLLBinetC.html\">Population: CLL und Binet Stadium C</a></p><p><b>date</b>: 2023-05</p><p><b>publisher</b>: https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll</p><p><b>description</b>: </p><div><p>Die Indikation zur Therapie besteht bei Übergang in Stadium Binet C</p>\n</div><h3>Actions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Definition[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 386053000}\">Evaluation procedure (procedure)</span></td><td><a href=\"ActivityDefinition-TherapieIndikationCLL.html\">TherapieIndikationCLL</a></td></tr></table></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-partOf",
      "valueCanonical" : "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommendation/therapeutic-anticoagulation"
    },
    {
      "extension" : [
        {
          "url" : "method",
          "valueCodeableConcept" : {
            "coding" : [
              {
                "system" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-action-combination-method",
                "code" : "all"
              }
            ]
          }
        }
      ],
      "url" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/ext-action-combination-method"
    },
    {
      "url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
      "valueCode" : "computable"
    },
    {
      "url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel",
      "valueCode" : "structured"
    }
  ],
  "url" : "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/PlanDefinition/CLLTherapieindikationBinetC",
  "version" : "Langversion 2.01",
  "name" : "CLLTherapieindikationBinetC",
  "title" : "CLL Therapieindikation Binet C",
  "type" : {
    "coding" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/plan-definition-type",
        "code" : "eca-rule"
      }
    ]
  },
  "status" : "active",
  "experimental" : false,
  "subjectCanonical" : "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/EvidenceVariable/PopulationCLLBinetC",
  "date" : "2023-05",
  "publisher" : "https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll",
  "description" : "Die Indikation zur Therapie besteht bei Übergang in Stadium Binet C",
  "action" : [
    {
      "code" : {
        "coding" : [
          {
            "system" : "http://snomed.info/sct",
            "code" : "386053000",
            "display" : "Evaluation procedure (procedure)"
          }
        ]
      },
      "definitionCanonical" : "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/ActivityDefinition/TherapieIndikationCLL"
    }
  ]
}